Common Contracts
33 similar Change of Control and Severance Agreement contracts by Veracyte, Inc., Audience Inc, CareDx, Inc.
CAREDX, INC. CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • November 4th, 2024 • CareDx, Inc. • Services-medical laboratories • California
This Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between Jessica Meng (“Executive”) and CareDx, Inc., a Delaware corporation (the “Company”), effective as of August 30, 2024 (the “Effective Date”).
CAREDX, INC. CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • April 16th, 2024 • CareDx, Inc. • Services-medical laboratories • California
This Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between John Hanna (“Executive”) and CareDx, Inc., a Delaware corporation (the “Company”), effective as of March 21, 2024 (the “Effective Date”).
VERACYTE, INC. CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • February 29th, 2024 • Veracyte, Inc. • Services-medical laboratories • California
This Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between John Leite (“Executive”) and Veracyte, Inc., a Delaware corporation (the “Company”), effective as of September 1, 2023 (the “Effective Date”).
VERACYTE, INC. CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • February 29th, 2024 • Veracyte, Inc. • Services-medical laboratories • California
This Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between Phil Febbo(“Executive”) and Veracyte, Inc., a Delaware corporation (the “Company”), effective as of October 2, 2023 (the “Effective Date”).
VERACYTE, INC. CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • March 1st, 2023 • Veracyte, Inc. • Services-medical laboratories • California
This Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between Ann McGuire (“Executive”) and Veracyte, Inc., a Delaware corporation (the “Company”), effective as of January 1, 2023 (the “Effective Date”).
VERACYTE, INC. CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • May 4th, 2022 • Veracyte, Inc. • Services-medical laboratories • California
This Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between Ann (Annie) McGuire. (“Executive”) and Veracyte, Inc., a Delaware corporation (the “Company”), effective as of February 28, 2022 (the “Effective Date”).
CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • May 4th, 2022 • Veracyte, Inc. • Services-medical laboratories • California
This Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between Tina S. Nova, PhD (“Executive”) and Veracyte, Inc., a Delaware corporation (the “Company”), effective as of the closing (the “Closing Date”) of the Company’s acquisition of Decipher Biosciences, Inc. (“Decipher”) pursuant to the Agreement and Plan of Merger by and between the Company and Decipher, and certain other parties, dated on or about February 2, 2021 (the “Effective Date”).
VERACYTE, INC. CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • November 9th, 2021 • Veracyte, Inc. • Services-medical laboratories • California
This Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between Rebecca Chambers (“Executive”) and Veracyte, Inc., a Delaware corporation (the “Company”), effective as of July 19, 2021 (the “Effective Date”).
VERACYTE, INC. CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • July 29th, 2021 • Veracyte, Inc. • Services-medical laboratories • California
This Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between Marc Stapley (“Executive”) and Veracyte, Inc., a Delaware corporation (the “Company”), effective as of June 1, 2021 (the “Effective Date”).
VERACYTE, INC. CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • February 22nd, 2021 • Veracyte, Inc. • Services-medical laboratories • California
This Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between James Erlinger III (“Executive”) and Veracyte, Inc., a Delaware corporation (the “Company”), effective as of August 1, 2020 (the “Effective Date”).
EX-10.10 22 d229773dex1010.htm CHANGE OF CONTROL SEVERANCE AGREEMENT AUDIENCE, INC. CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • May 5th, 2020 • California
This Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between Peter Santos (“Executive”) and Audience, Inc., a Delaware corporation (the “Company”), effective as of December 31, 2011 (the “Effective Date”).
VERACYTE, INC. AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • July 30th, 2019 • Veracyte, Inc. • Services-medical laboratories • California
This Amended and Restated Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between Keith Kennedy (“Executive”) and Veracyte, Inc., a Delaware corporation (the “Company”), effective as of July 1, 2019 (the “Effective Date”). This Agreement amends and restates the Change of Control and Severance Agreement by and between the Executive and the Company, effective as of October 23, 2018 (the “Prior Agreement”).
VERACYTE, INC. AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • July 30th, 2019 • Veracyte, Inc. • Services-medical laboratories • California
This Amended and Restated Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between John Hanna (“Executive”) and Veracyte, Inc., a Delaware corporation (the “Company”), effective as of July 1, 2019 (the “Effective Date”). This Agreement amends and restates the Change of Control and Severance Agreement by and between the Executive and the Company, effective as of October 23, 2018 (the “Prior Agreement”).
VERACYTE, INC. AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • July 30th, 2019 • Veracyte, Inc. • Services-medical laboratories • California
This Amended and Restated Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between Giulia Kennedy (“Executive”) and Veracyte, Inc., a Delaware corporation (the “Company”), effective as of July 1, 2019 (the “Effective Date”). This Agreement amends and restates the Change of Control and Severance Agreement by and between the Executive and the Company, effective as of October 23, 2018 (the “Prior Agreement”).
VERACYTE, INC. AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • July 30th, 2019 • Veracyte, Inc. • Services-medical laboratories • California
This Amended and Restated Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between Bonnie Anderson (“Executive”) and Veracyte, Inc., a Delaware corporation (the “Company”), effective as of July 1, 2019 (the “Effective Date”). This Agreement amends and restates the Amended and Restated Change of Control and Severance Agreement by and between the Executive and the Company, effective as of October 23, 2018 (the “Prior Agreement”).
VERACYTE, INC. AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • February 25th, 2019 • Veracyte, Inc. • Services-medical laboratories • California
This Amended and Restated Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between Bonnie Anderson (“Executive”) and Veracyte, Inc., a Delaware corporation (the “Company”), effective as of October 23, 2018 (the “Effective Date”). This Agreement amends and restates the Amended and Restated Change of Control and Severance Agreement by and between the Executive and the Company, effective as of May 14, 2015 (the “Prior Agreement”).
VERACYTE, INC. AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • February 25th, 2019 • Veracyte, Inc. • Services-medical laboratories • California
This Amended and Restated Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between Keith Kennedy (“Executive”) and Veracyte, Inc., a Delaware corporation (the “Company”), effective as of October 23, 2018 (the “Effective Date”). This Agreement amends and restates the Change of Control and Severance Agreement by and between the Executive and the Company, effective as of February 15, 2017 (the “Prior Agreement”).
VERACYTE, INC. AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • February 25th, 2019 • Veracyte, Inc. • Services-medical laboratories • California
This Amended and Restated Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between Christopher Hall (“Executive”) and Veracyte, Inc., a Delaware corporation (the “Company”), effective as of October 23, 2018 (the “Effective Date”). This Agreement amends and restates the Amended and Restated Change of Control and Severance Agreement by and between the Executive and the Company, effective as of May 14, 2015 (the “Prior Agreement”).
VERACYTE, INC. CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • March 1st, 2017 • Veracyte, Inc. • Services-medical laboratories • California
This Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between Keith Kennedy (“Executive”) and Veracyte, Inc., a Delaware corporation (the “Company”), effective as of February 15, 2017 (the “Effective Date”).
VERACYTE, INC. AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • May 15th, 2015 • Veracyte, Inc. • Services-medical laboratories • California
This Amended and Restated Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between Bonnie Anderson (“Executive”) and Veracyte, Inc., a Delaware corporation (the “Company”), effective as of May 14, 2015 (the “Effective Date”).
VERACYTE, INC. AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • May 15th, 2015 • Veracyte, Inc. • Services-medical laboratories • California
This Amended and Restated Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between Shelly Guyer (“Executive”) and Veracyte, Inc., a Delaware corporation (the “Company”), effective as of May 14, 2015 (the “Effective Date”).
VERACYTE, INC. AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • May 15th, 2015 • Veracyte, Inc. • Services-medical laboratories • California
This Amended and Restated Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between Julie Brooks (“Executive”) and Veracyte, Inc., a Delaware corporation (the “Company”), effective as of May 14, 2015 (the “Effective Date”).
VERACYTE, INC. AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • May 15th, 2015 • Veracyte, Inc. • Services-medical laboratories • California
This Amended and Restated Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between Christopher Hall (“Executive”) and Veracyte, Inc., a Delaware corporation (the “Company”), effective as of May 14, 2015 (the “Effective Date”).
CAREDX, INC. CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • June 3rd, 2014 • CareDx, Inc. • Services-medical laboratories • California
This Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between [ ] (“Executive”) and CareDx, Inc., a Delaware corporation (the “Company”), effective as of [ ] (the “Effective Date”).
VERACYTE, INC. CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • September 20th, 2013 • Veracyte, Inc. • Services-medical laboratories • California
This Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between Bonnie Anderson (“Executive”) and Veracyte, Inc., a Delaware corporation (the “Company”), effective as of August 24, 2012 (the “Effective Date”).
VERACYTE, INC. CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • September 20th, 2013 • Veracyte, Inc. • Services-medical laboratories • California
This Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between Shelly Guyer (“Executive”) and Veracyte, Inc., a Delaware corporation (the “Company”), effective as of April 8, 2013 (the “Effective Date”).
VERACYTE, INC. CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • September 20th, 2013 • Veracyte, Inc. • Services-medical laboratories • California
This Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between Christopher Hail (“Executive”) and Veracyte, Inc., a Delaware corporation (the “Company”), effective as of August 24, 2012 (the “Effective Date”).
VERACYTE, INC. CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • August 13th, 2013 • Veracyte, Inc. • Services-medical laboratories • California
This Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between Shelly Guyer (“Executive”) and Veracyte, Inc., a Delaware corporation (the “Company”), effective as of April 8, 2013 (the “Effective Date”).
VERACYTE, INC. CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • August 13th, 2013 • Veracyte, Inc. • Services-medical laboratories • California
This Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between Christopher Hail (“Executive”) and Veracyte, Inc., a Delaware corporation (the “Company”), effective as of August 24, 2012 (the “Effective Date”).
VERACYTE, INC. CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • August 13th, 2013 • Veracyte, Inc. • Services-medical laboratories • California
This Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between Bonnie Anderson (“Executive”) and Veracyte, Inc., a Delaware corporation (the “Company”), effective as of August 24, 2012 (the “Effective Date”).
AUDIENCE, INC. CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • January 13th, 2012 • Audience Inc • California
This Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between [ ] (“Executive”) and Audience, Inc., a Delaware corporation (the “Company”), effective as of December 31, 2011 (the “Effective Date”).
AUDIENCE, INC. CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • January 13th, 2012 • Audience Inc • California
This Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between Kevin S. Palatnik (“Executive”) and Audience, Inc., a Delaware corporation (the “Company”), effective as of December 31, 2011 (the “Effective Date”).
AUDIENCE, INC. CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • January 13th, 2012 • Audience Inc • California
This Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between Peter Santos (“Executive”) and Audience, Inc., a Delaware corporation (the “Company”), effective as of December 31, 2011 (the “Effective Date”).
